These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 8476777

  • 1. Competitive product inhibition of aromatase by natural estrogens.
    Shimizu Y, Yarborough C, Osawa Y.
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):651-6. PubMed ID: 8476777
    [Abstract] [Full Text] [Related]

  • 2. Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase.
    Osawa Y, Higashiyama T, Shimizu Y, Yarborough C.
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):469-80. PubMed ID: 8476762
    [Abstract] [Full Text] [Related]

  • 3. Equine cytochrome P450 aromatase exhibits an estrogen 2-hydroxylase activity in vitro.
    Almadhidi J, Moslemi S, Drosdowsky MA, Séralini GE.
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):55-61. PubMed ID: 9009238
    [Abstract] [Full Text] [Related]

  • 4. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
    Swinney DC, Watson DM, So OY.
    Arch Biochem Biophys; 1993 Aug 15; 305(1):61-7. PubMed ID: 8342956
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H, Bartsch W, Niemand A, Stürenburg HJ, Voigt KD.
    J Steroid Biochem; 1988 Feb 15; 29(2):161-9. PubMed ID: 3347056
    [Abstract] [Full Text] [Related]

  • 6. Substrate specificity of the placental microsomal aromatase.
    Gibb W, Lavoie JC.
    Steroids; 1980 Nov 15; 36(5):507-19. PubMed ID: 7456098
    [Abstract] [Full Text] [Related]

  • 7. A comparison of methods measuring aromatase activity in human placenta and rat ovary.
    Purba HS, Bhatnagar AS.
    J Enzyme Inhib; 1990 Nov 15; 4(2):169-78. PubMed ID: 2151521
    [Abstract] [Full Text] [Related]

  • 8. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
    Numazawa M, Yoshimura A, Tachibana M, Shelangouski M, Ishikawa M.
    Steroids; 2002 Mar 15; 67(3-4):185-93. PubMed ID: 11856542
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of human estrogen synthetase (aromatase) by flavones.
    Kellis JT, Vickery LE.
    Science; 1984 Sep 07; 225(4666):1032-4. PubMed ID: 6474163
    [Abstract] [Full Text] [Related]

  • 10. Kinetic properties of human placental aromatase. Application of an assay measuring 3H2O release from 1beta,2beta-3H-androgens.
    Reed KC, Ohno S.
    J Biol Chem; 1976 Mar 25; 251(6):1625-31. PubMed ID: 3502
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT, Vickery LE.
    Endocrinology; 1984 Jun 25; 114(6):2128-37. PubMed ID: 6723577
    [Abstract] [Full Text] [Related]

  • 12. Radiometric analysis of oxidative reactions in aromatization by placental microsomes. Presence of differential isotope effects.
    Miyairi S, Fishman J.
    J Biol Chem; 1985 Jan 10; 260(1):320-5. PubMed ID: 3880740
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of aromatase activity in human placental microsomes by 13-retro-antiprogestins.
    Shimizu Y, Yarborough CP, Elger W, Chwalisz K, Osawa Y.
    Steroids; 1995 Feb 10; 60(2):234-8. PubMed ID: 7618191
    [Abstract] [Full Text] [Related]

  • 14. Aromatase and estrogen 2-hydroxylase activities of human placental microsomes in pregnancy-induced hypertension.
    Okubo K, Jinbo M, Toma Y, Shimizu Y, Yanaihara T.
    Endocr J; 1996 Aug 10; 43(4):363-8. PubMed ID: 8930523
    [Abstract] [Full Text] [Related]

  • 15. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
    Schmidt M, Weidler C, Naumann H, Anders S, Schölmerich J, Straub RH.
    Arthritis Res Ther; 2005 Aug 10; 7(5):R938-48. PubMed ID: 16207335
    [Abstract] [Full Text] [Related]

  • 16. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M, Mutsumi A, Tachibana M, Yoshimura A.
    Biol Pharm Bull; 2003 Jun 10; 26(6):890-2. PubMed ID: 12808307
    [Abstract] [Full Text] [Related]

  • 17. [Aromatization of androstenedione and 19-nortestosterone in human placenta, liver and adipose tissues].
    Yoshiji S, Yamamoto T, Okada H.
    Nihon Naibunpi Gakkai Zasshi; 1986 Jan 20; 62(1):18-25. PubMed ID: 3699194
    [Abstract] [Full Text] [Related]

  • 18. 3-Methylene-substituted androgens as novel aromatization inhibitors. Evidence of a requirement for C-3 oxygen in C-19 hydroxylations.
    Miyairi S, Fishman J.
    J Biol Chem; 1986 May 25; 261(15):6772-7. PubMed ID: 3700413
    [Abstract] [Full Text] [Related]

  • 19. Immunoaffinity purification of aromatase cytochrome P-450 from human placental microsomes, metabolic switching from aromatization to 1 beta and 2 beta-monohydroxylation, and recognition of aromatase isozymes.
    Osawa Y, Yoshida N, Fronckowiak M, Kitawaki J.
    Steroids; 1987 May 25; 50(1-3):11-28. PubMed ID: 3142109
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts.
    Nestler JE.
    Endocrinology; 1993 Feb 25; 132(2):566-70. PubMed ID: 8425476
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.